Current Opinion in Neurology

Article	Citations
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation	74
Management of neuropsychiatric symptoms in dementia	63
Update on management of cerebral venous thrombosis	60
The recent surge of functional movement disorders: social distress or greater awareness?	52
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis	49
Assessing treatment response in multiple sclerosis	49
From basic mechanisms to therapeutic perspectives in cluster headache	47
Editorial introductions	47
The 2021 WHO classification of central nervous system tumors: what neurologists need to know	44
Microglia in multiple sclerosis – pathogenesis and imaging	40
Neuro-oncology is moving quickly toward new horizons of diagnosis and treatment	38
Hereditary motor neuropathies	37
The role of the gut microbiome in Alzheimer's disease pathophysiology	36
Neurosyphilis in 2025: Erratum	35
Neurology education in the era of artificial intelligence	35
Decoding Alzheimer's disease through down syndrome: insights from a genetically defined population	34
Integration over reduction: multimodal PET and fluid biomarkers in Alzheimer's disease and beyond	30
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies	28
Historical development and contemporary use of neuromodulation in human spinal cord injury	28
Updates in neuro-otology	27
Central nervous system adverse events of immune checkpoint inhibitors	27
Editorial introductions	27
Gene therapies for CMT neuropathies: from the bench to the clinic	27
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection	26
Editorial: Epilepsy advances in 2023	26

Multiple sclerosis in China: the current state of diagnosis and management	25
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial	25
Connecting tremors – a circuits perspective	24
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise	24
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke	23
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery	23
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management	23
Update on the clinical and therapeutic aspects of myotonic dystrophy type 1	22
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms	22
Thymectomy in myasthenia gravis	21
Migraine in women: a review	21
Global to individual: key domains of burden in pediatric headache	21
The FSHD jigsaw: are we placing the tiles in the right position?	21
Threat of resurgence or hope for global eradication of poliovirus?	21
Clinical impact of molecular profiling in rare brain tumors	20
Levodopa infusion therapies for Parkinson disease	20
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment	20
Nerve ultrasound in the diagnosis of inflammatory neuropathies	20
fMRI-based spatio-temporal parcellations of the human brain	19
Diet and migraine: what is proven?	19
MRI for the diagnosis of limb girdle muscular dystrophies	19
Red flags in multiple sclerosis	19
Gauging and controlling excitability in cortical disorders	18
MRI in multiple sclerosis: progress in in-vivo pathobiology	18
Novel pharmacological therapies in development	18
Obesity-related neuropathy: the new epidemic	18
Acute stroke care in low and middle-income countries	18
Update on dermatomyositis	18
Electrical stimulation of the peripheral and central vestibular system	18
Targeting IDH1/IDH2 mutations in gliomas	17
Editorial: The gap between academic advances and therapy development in motor neuron disease	17
Idiopathic intracranial hypertension: expanding our understanding	17
Parkinson's disease – genetic cause	17
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis	16
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers	16
Autoimmune encephalitis and paraneoplastic neurologic syndrome: clinical diagnosis	16
Editorial introductions	16
Optic neuritis: current challenges in diagnosis and management	16
Progress in spinal muscular atrophy research	16
Novel approaches to treatment of leptomeningeal metastases	16
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications	16
Recent advances in Alzheimer disease genetics	16
Neuroinflammation and immunometabolism in neurodegenerative diseases	16
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond	15
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management	15
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies	15
The state of art on the use of patient reported outcomes in migraine	15
Sex and gender differences in neurological infections	15
New developments in diagnostics and treatment of adult-onset focal dystonia	15
Monitoring multiple sclerosis: digital and fluid phase biomarkers	15

Neurosyphilis in 2025	15
Update on genetics of amyotrophic lateral sclerosis	14
Abnormal energy metabolism in ALS: a key player?	14
Recent insights in striated muscle laminopathies	14
Fluid phase biomarkers in multiple sclerosis	14
The monoaminergic systems as drivers of Alzheimer's disease pathophysiology and symptomatology	14
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health	14
Diagnosing viral encephalitis and emerging concepts	14
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum	13
Update on modifiable risk factors for Alzheimer's disease and related dementias	13
PET imaging of microglial pathology in multiple sclerosis	13
Imaging of vestibular function and disorders and its clinical relevance	13
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders	13
Current trend in air pollution exposure and stroke	13
Converging perspectives in vestibular neurology	13
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease	13
Imaging cortical lesions in multiple sclerosis	13
New insights in the immune treatment of Guillain–Barré syndrome	13
Precision medicine in Moyamoya vasculopathy	13
Editorial introductions	13
Editorial: Seizure disorders: 2023 update	12
Immune checkpoint inhibitors induced side effects of the peripheral nervous system	12
Peripheral visual field loss and activities of daily living	12
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy	12
Vestibular migraine. Clinical and diagnostic challenges, and emerging therapeutic approaches	12
Current gaps in acute reperfusion therapies	12
Genetic role in autoimmune encephalitis and paraneoplastic neurological syndromes	11
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients	11
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period	11
Multiple sclerosis: advances and challenges in diagnosis	11
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review	11
Progress in treatment of gliomas	11
Editorial: Cerebrovascular disease	11
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury	11
Muscle ultrasound in myopathies	11
Long COVID and especially headache syndromes	11
Nonneurologic causes of binocular diplopia for the neurologist	11
Update on functional vestibular and gait disorders	11
Editorial: Advances in brain tumors management: new perspectives and challenges	10
Interrogating large multiple sclerosis registries and databases: what information can be gained?	10
Progression in multiple sclerosis – a long-term problem	10
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success	10
Editorial introductions	10
Deep brain stimulation of the mesencephalic locomotor region or lateral hypothalamus for facilitation of walking after spinal cord injury	10
Therapeutic thoroughfares for adults living with Pompe disease	10
Perception and control of a virtual body in immersive virtual reality for rehabilitation	10
Neuro-infectious disorders – reasons to be cheerful but it is a long and winding road	10
Emerging concepts and therapies for amyotrophic lateral sclerosis	10
An update on psychogenic nonepileptic seizures	10
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?	10
Editorial introductions	10
Acute vertigo: stroke or not?	9
Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment	9
AI in epilepsy neuroimaging	9
Editorial:Framing artificial intelligence to neuromuscular disorders	9
Barriers to clinical genetic testing in movement disorders	9
The current landscape of epilepsy genetics: where are we, and where are we going?	9
Atypical forms of Alzheimer's disease: patients not to forget	9
How to evaluate extent of resection in diffuse gliomas: from standards to new methods	9
New targets in spontaneous intracerebral hemorrhage	9
Editorial improving movement disorders healthcare across the globe	8
Shifting our attention earlier in the multiple sclerosis disease course	8
Guillain-Barré syndrome in an era of global infections and 21st century vaccination	8
Promises and pitfalls of imaging-based biomarkers in motor neuron diseases	8
Artificial intelligence in neuroimaging of brain tumors: reality or still promise?	8
Editorial: Current opinions in neurology editorial	8
PET-based brain molecular connectivity in neurodegenerative disease	8
Endogenous clues promoting remyelination in multiple sclerosis	8
Editorial introductions	8
Deep brain stimulation access in 2025: geographic, gender, racial, and socioeconomic disparities re-examined	8
Lesion network mapping for symptom localization: recent developments and future directions	8
New-onset refractory status epilepticus and febrile infection-related epilepsy syndrome	8
Imaging and neuromodulation in Parkinson's disease	8
Ultra-high dose methylcobalamin and other emerging therapies for amyotrophic lateral sclerosis	7
The genetics of multiple sclerosis: an updated perspective	7
Congenital myasthenic syndromes: increasingly complex	7
Leprous neuropathy	7
Recent advances in stroke biomarkers – implications for prognosis and treatment	7
Neuroinflammation in amyotrophic lateral sclerosis: pathogenic insights and therapeutic implications	7
Clinical amyloid and tau positron emission tomography imaging in Alzheimer's disease: image interpretation in the era of anti-amyloid therapies	7

Editorial: Update on movement disorders	7
Autoimmune neuromyotonia	7
Headache in infections	7
The genetics of amyotrophic lateral sclerosis	7
Recent insights into haematology and peripheral nerve disease	7
The role of caffeine in headache disorders	7
Novel pathophysiological insights in autoimmune myasthenia gravis	6
Brain health in HIV: pathogenesis, classification, and treatment	6
Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update	6
Neuroimaging endpoints for clinical trials in gliomas: the neuro-oncologist perspective	6
Recent advances in epilepsy surgery	6
Medical and neurologic management of brain tumor patients	6
Editorial introductions	6
Genetics of ALS – genes and modifier	6
An update on multiple system atrophy	6
Progress in the mechanism of neuronal surface P antigen modulating hippocampal function and implications for autoimmune brain disease	6
Editorial introductions	6
Emerging neuroinfectious diseases: public health implications	6
Update on myelin imaging in neurological syndromes	6
Clinical characteristics of patients with myelin oligodendrocyte glycoprotein antibodies	6
Recent advances in the genetics of Parkinson's disease in underrepresented populations	6
Mechanisms of paraneoplastic neurological syndromes	5
Neurotoxicity from chimeric antigen receptor T-cells: an update on diagnosis and treatment	5
Spasticity following brain and spinal cord injury: assessment and treatment	5
Recent developments in multiple sclerosis neuropathology	5
Novel trial designs in neuro-oncology	5
Advances in myopathy research: promising developments and challenges	5
Pathomechanisms in demyelination and astrocytopathy: autoantibodies to AQP4, MOG, GFAP, GRP78 and beyond	5
Does imaging of the ischemic penumbra have value in acute ischemic stroke with large vessel occlusion?	5
The challenge of amyotrophic lateral sclerosis descriptive epidemiology: to estimate low incidence rates across complex phenotypes in different geographic areas	5
Current understanding of skeletal muscle repeat expansion disorders	5
Current drug treatment of myasthenia gravis	5
Epilepsy advances in 2025	5
The current clinical perception of myotonic dystrophy type 2	5
Systemic vasculitis and headache	5
The evolving spectrum of complex inherited neuropathies	5
Persistent aura without infarction	5
Ambulatory seizure detection	5
Vestibular syncope	5
Defining the presymptomatic phase of frontotemporal dementia	5
Movement disorders in COVID-19 times: impact on care in movement disorders and Parkinson disease	5
Heterogeneity of frequencies of motor neuron disease across ethnicities and geographical areas: focus on Arabic countries in the Mediterranean area	5
Assessment and treatment of neurogenic dysphagia in stroke and Parkinson's disease	5
Autoimmune nodopathies, an emerging diagnostic category	5
Enzyme replacement therapies in adults with Pompe disease: from trials to real-world data	4
Somatic mosaicism in focal epilepsies	4
Imaging of sleep disorders in pre-Parkinsonian syndromes	4
Editorial introductions	4
How can you manage an indomethacin-responsive headache in someone who cannot take indomethacin?	4
Advances in functional and structural imaging of the brainstem: implications for disease	4
Neuroscience and oncology: state-of-the-art and new perspectives	4
Reproducibility and replicability in neuroimaging data analysis	4
Noninvasive methods to monitor intracranial pressure	4
Nerve ultrasound for the diagnosis and follow-up of peripheral neuropathies	4
Describing and assessing behavioural symptoms in amyotrophic lateral sclerosis with and without frontotemporal dementia: a scoping review	4
Updates for newly diagnosed and recurrent glioblastoma: a review of recent clinical trials	4
Big data in multiple sclerosis	4
Recent advances in our understanding of genetic rhabdomyolysis	4
Diagnostic criteria for amyotrophic lateral sclerosis	4
Progress in the identification of unstable carotid artery plaque	4
The atypical faces of optic neuritis: neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease	4
Neuro-vestibular rehab: new developments	4
Immunology of multiple sclerosis: an update	4
Late-onset myopathies	4
Recent advances, challenges and perspectives in cerebrovascular disease	4
Promoting exogenous repair in multiple sclerosis: myelin regeneration	4
Editorial: Neuromuscular diseases: differential diagnosis and targeted treatment	4
The impact of climate change on neuroinfectious diseases	4
The cortical vestibular system: insights from electroencephalography	4
Noninvasive brain stimulation to improve motor outcomes after stroke	4
Traumatic brachial plexus injury: diagnosis and treatment	4